Polycystic ovary syndrome: An updated review
Authors:
- 1 January 2019
- journal article
- review article
- Published by Wolters Kluwer Health in International Journal of Health & Allied Sciences
- Vol. 8 (4) , 229-235
Abstract
Polycystic ovary syndrome (PCOS) is one of the most common metabolic and reproductive disorders among the reproductive age women. PCOS presents with the symptoms of androgen excess, menstrual dysfunction, hirsutism, acne, and obesity, which significantly impacts their quality of life. It not only a reproductive problem but also as a severe metabolic disease that carries crucial health risks as age increases. PCOS has an increased risk of multiple morbidities, including insulin resistance, type II diabetes mellitus, obesity, cardiovascular disease, cancer, infertility, and psychological disorders. This review summarizes that the literature has so far provided from guidelines to diagnosis of PCOS and also this review gives a general overview about the morbidities associated with PCOS, specifically with its more severe classic form. Finally, the review will stress on the various aspects of treatment currently used in the management of this condition.Keywords
This publication has 38 references indexed in Scilit:
- Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop GroupFertility and Sterility, 2012
- Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding studyFertility and Sterility, 2011
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndromeEuropean Journal of Endocrinology, 2011
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanBMC Medicine, 2010
- Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)Fertility and Sterility, 2010
- Metabolic features of the reproductive phenotypes of polycystic ovary syndromeHuman Reproduction Update, 2009
- Metformin Decreases the Adipokine Vaspin in Overweight Women With Polycystic Ovary Syndrome Concomitant With Improvement in Insulin Sensitivity and a Decrease in Insulin ResistanceDiabetes, 2008
- RETRACTED: Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trialFertility and Sterility, 2008
- Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndromeFertility and Sterility, 2007
- Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)Journal of Clinical Pathology, 2005